[Biological investigations on the properties of modified zinc-oxide-eugenol cements and endomethasone].
Limanowska
H
H
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000633:toxicity; D001419:Bacteria / Q000187:drug effects; D001672:Biocompatible Materials; D003907:Dexamethasone / Q000494:pharmacology / Q000633:toxicity; D004338:Drug Combinations / Q000494:pharmacology / Q000633:toxicity; D005557:Formaldehyde / Q000494:pharmacology / Q000633:toxicity; D006854:Hydrocortisone; D008826:Microbial Sensitivity Tests; D013943:Thymol / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000633:toxicity; D015035:Zinc Oxide-Eugenol Cement / Q000494:pharmacology / Q000633:toxicity
D000893:Anti-Inflammatory Agents; D001672:Biocompatible Materials; D004338:Drug Combinations; D015035:Zinc Oxide-Eugenol Cement; C011244:corticosteroid methanetriol mixture; D005557:Formaldehyde; D013943:Thymol; D003907:Dexamethasone; D006854:Hydrocortisone
Badania biologidznych właściwości zmodyfikowanych cementów tlenkowo-cynkowo-eugenolowych oraz endomethasonu.